Mobile Health Application (PACT) to Improve Engagement in Advance Care Planning

Description

This clinical trial tests a new mobile health application (app) called Planning Advance Care Together (PACT) to help people with cancer talk about and plan for advance care planning (the care they would want if they were unable to communicate) with their loved ones and doctors. The development of the PACT mobile app may help future patients incorporate their social network (typically, but not exclusively, family) into the advance care planning process.

Conditions

Malignant Solid Neoplasm

Talk to us

Study Overview

On this page

Study Details

Study overview

This clinical trial tests a new mobile health application (app) called Planning Advance Care Together (PACT) to help people with cancer talk about and plan for advance care planning (the care they would want if they were unable to communicate) with their loved ones and doctors. The development of the PACT mobile app may help future patients incorporate their social network (typically, but not exclusively, family) into the advance care planning process.

Planning Advance Care Together (PACT) to Improve Engagement in Advance Care Planning

Mobile Health Application (PACT) to Improve Engagement in Advance Care Planning

Condition
Malignant Solid Neoplasm
Intervention / Treatment

-

Contacts and Locations

Manhasset

Northwell Health, Manhasset, New York, United States, 11030

New York

Mount Sinai Hospital, New York, New York, United States, 10029

New York

NYP/Weill Cornell Medical Center, New York, New York, United States, 10065

Seattle

Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States, 98109

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * PATIENT: Diagnosis of poor prognosis advanced cancer defined as locally advanced or metastatic cancer and/or disease progression following at least first line systemic therapy.
  • * PATIENT: Access to a mobile device; the principal investigator (PI) will ensure that those who have access to a mobile device have access to a mobile device with internet access to ensure they can complete study procedures.
  • * PATIENT: The ability to provide informed consent.
  • * PATIENT: Identification and enrollment of a loved support person.
  • * PATIENT: 18 years of age or older.
  • * SUPPORT PERSON: The person (family member or friend) whom the patient indicates being a support person.
  • * SUPPORT PERSON: English speaking.
  • * SUPPORT PERSON: 18 years of age or older and able to provide informed consent.
  • * PROVIDER: Current clinical practice and/or research with advanced cancer patients.
  • * PROVIDER: A history of 3+ years working with advanced cancer patients.
  • * PROVIDER: 18 years of age or older. Providers across disciplines (e.g., social work, oncology) will be enrolled.
  • * PATIENT: Not fluent in English.
  • * PATIENT: Severely cognitively impaired (as measured by Short Portable Mental Status Questionnaire scores of \>= 6) to be delivered by trained study research staff during screening.
  • * PATIENT: Too ill or weak to complete the interviews (as judged by the interviewer).
  • * PATIENT: Currently receiving hospice at the time of enrollment.
  • * PATIENT: Children and young adults under age 18.
  • * PATIENT: Resides outside of the United States.
  • * SUPPORT PERSON AND PROVIDERS: Resides outside of the United States.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Fred Hutchinson Cancer Center,

Megan J Shen, PhD, PRINCIPAL_INVESTIGATOR, Fred Hutch/University of Washington Cancer Consortium

Study Record Dates

2025-12-31